This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Jim Cramer

Real Money Columnist

Jim Cramer is one of America's most recognized and respected investment pros and media personalities. He runs Action Alerts PLUS, a charitable trust portfolio. In 1996, Jim founded TheStreet, one of the "most visited" financial media websites for individual to institutional investors. Jim also writes daily market commentary for TheStreet's Real Money premium service, and participates in video segments on TheStreet TV. He also serves as host of CNBC's "Mad Money" television program.

Jim graduated magna cum laude from Harvard College, where he was president of The Harvard Crimson. He went on to earn a law degree from Harvard Law School in 1984. From there Jim joined Goldman Sachs, where he worked in sales and trading. In 1987, he left Goldman to start his own hedge fund. While still managing his fund, Jim helped start Smart Money for Dow Jones. He is the author of Confessions of a Street Addict, You Got Screwed, Jim Cramer's Real Money, Jim Cramer's Mad Money, Jim Cramer's Stay Mad for Life, Jim Cramer's Getting Back to Even and, his newest book, Jim Cramer's Get Rich Carefully. Jim has written for Time magazine and New York magazine and has been featured on CBS' 60 Minutes, NBC's Nightly News with Brian Williams, Meet the Press, Today, The Tonight Show, Late Night and MSNBC's Morning Joe.

By This Author:
Page 3 of 4815

Dicker/Cramer: Buy Halliburton as It Attempts to Buy Baker Hughes

By Jim Cramer

Dan Dicker, Senior Energy contributor to Thestreet, talks to Jim Cramer about the recent buy of Baker Hughes (BHI) by Halliburton (HAL).

01:00PM 11/19/14

Cramer Explains Why He Likes Agios Pharmaceuticals (AGIO)

By Jim Cramer

Cramer says Agios Pharmaceuticals is unique and different and yesterday its experimental cancer drug delivered some strong results in patients with advanced leukemia.

12:31PM 11/19/14

Jim Cramer Feels Skeptical About Morgan Stanley's Tesla Report

By Jim Cramer

Jim Cramer says it makes him skeptical when Morgan Stanley cuts its expectations for Tesla Motors 2015 Model X deliveries but reiterates an overweight rating and $320 price target.

11:13AM 11/19/14

Jim Cramer: Stock Buybacks, Dividends Are Trumping Vision

By Jim Cramer

Companies with smaller visions but bigger buybacks rule right now.

09:47AM 11/19/14

Jim Cramer Says Get GoPro Stock Ahead of Secondary Offering

By Jim Cramer

GoPro announced late Monday that it will have a secondary offering of 10..4 million shares.

02:55PM 11/18/14

Jim Cramer: TJX Weakness Due to Unfavorable FX Exposure in Europe

By Jim Cramer

Jim Cramer says TJX missed sales estimates largely as a result of unfavorable FX exposure in Europe, not because its domestic business is struggling.

12:36PM 11/18/14


McDonald's Strategy Is Promising (Action Alerts PLUS $)

By Jim Cramer

We will watch for weakness to add shares.

11:54AM 11/18/14

Jim Cramer: Great Quarter for Home Depot Despite Mixed Earnings

By Jim Cramer

Home Depot stock was down following the release of its results but Jim Cramer says that doesn't mean it wasn't a great quarter for the country's largest home improvement chain.

11:52AM 11/18/14

Cramer Answers Twitter Questions on Gold, Twitter, Gilead, Energy

By Jim Cramer

Jim Cramer answers viewers' Twitter questions from the floor of the New York Stock Exchange.

01:19PM 11/17/14

Page 3 of 4815

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 17,806.37 -3.69 -0.02%
S&P 500 2,067.88 +4.38 0.21%
NASDAQ 4,749.1770 +36.2070 0.77%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs